Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Preserved DNA from past clinical trials yields new information about a subtype of alcoholism.

× No keyword cloud information.

14 in total

Review 1. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.

Authors: Helen M Pettinati; Charles P O'Brien; Amanda R Rabinowitz; Shoshana P Wortman; David W Oslin; Kyle M Kampman; Charles A Dackis
Journal: J Clin Psychopharmacol Date: 2006-12 Impact factor: 3.153

2. Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the mu-opioid receptor locus (OPRM1).

Authors: Carlos A Hernandez-Avila; Gary Wand; Xingguang Luo; Joel Gelernter; Henry R Kranzler
Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2003-04-01 Impact factor: 3.568

3. Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study.

Authors: Joel Gelernter; Ralitza Gueorguieva; Henry R Kranzler; Huiping Zhang; Joyce Cramer; Robert Rosenheck; John H Krystal
Journal: Alcohol Clin Exp Res Date: 2007-04 Impact factor: 3.455

4. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

Authors: Raymond F Anton; Stephanie S O'Malley; Domenic A Ciraulo; Ron A Cisler; David Couper; Dennis M Donovan; David R Gastfriend; James D Hosking; Bankole A Johnson; Joseph S LoCastro; Richard Longabaugh; Barbara J Mason; Margaret E Mattson; William R Miller; Helen M Pettinati; Carrie L Randall; Robert Swift; Roger D Weiss; Lauren D Williams; Allen Zweben
Journal: JAMA Date: 2006-05-03 Impact factor: 56.272

5. Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence.

Authors: A C King; J R Volpicelli; A Frazer; C P O'Brien
Journal: Psychopharmacology (Berl) Date: 1997-01 Impact factor: 4.530

6. Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study.

Authors: Lara A Ray; Kent E Hutchison
Journal: Arch Gen Psychiatry Date: 2007-09

7. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction.

Authors: C Bond; K S LaForge; M Tian; D Melia; S Zhang; L Borg; J Gong; J Schluger; J A Strong; S M Leal; J A Tischfield; M J Kreek; L Yu
Journal: Proc Natl Acad Sci U S A Date: 1998-08-04 Impact factor: 11.205

8. Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers.

Authors: Albert J Arias; Stephen Armeli; Joel Gelernter; Jonathan Covault; Antero Kallio; Sakari Karhuvaara; Tiina Koivisto; Rauno Mäkelä; Henry R Kranzler
Journal: Alcohol Clin Exp Res Date: 2008-07 Impact factor: 3.455

9. Suppression of ethanol-reinforced behavior by naltrexone is associated with attenuation of the ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens.

Authors: R A Gonzales; F Weiss
Journal: J Neurosci Date: 1998-12-15 Impact factor: 6.167

10. Naltrexone in the treatment of alcohol dependence.

Authors: J R Volpicelli; A I Alterman; M Hayashida; C P O'Brien
Journal: Arch Gen Psychiatry Date: 1992-11